Reshaping Australian drug policy: the dilemmas of generic medicines policy
2007

Reshaping Australian Drug Policy

Commentary

Author Information

Author(s): Hans Löfgren

Primary Institution: Deakin University

Hypothesis

How can Australia improve its drug policy to promote the use of generic medicines?

Conclusion

The new drug policy aims to lower prices for off-patent medicines and improve access to generics in Australia.

Supporting Evidence

  • Most medicines can be made cheaply, especially generics.
  • The Australian government is introducing changes to drug policy to promote cheaper generics.
  • Generic drugs account for a significant portion of PBS expenditure.
  • Pricing incentives for choosing generics over brand names are currently weak.

Takeaway

Australia is trying to make medicines cheaper by using more generic drugs, which are often less expensive than brand-name ones.

Limitations

The implications of the new policy are still uncertain and many details are yet to be finalized.

Digital Object Identifier (DOI)

10.1186/1743-8462-4-11

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication